PropertyValue
?:abstract
  • The Drug Information Association (DIA) Europe 2020 brought together multiple stakeholders from around the world including regulatory agencies, industry, patients and academia, to discuss the most innovative topics in healthcare. Main subjects covered were regulatory science, data and data standards, clinical safety and pharmacovigilance, translational medicines and science, patient engagement in clinical development, value and access, medical affairs and scientific communication, health policy, and public affairs and legal issues. The meeting, which was initially intended to take place in Brussels, was finally held virtually due to the COVID-19 situation. This report covers some of the sessions held on these 5 days of state-of-the-art topic discussions.
?:creator
?:doi
?:doi
  • 10.1358/dot.2020.56.9.3208177
?:journal
  • Drugs_of_today
?:license
  • unk
?:pmid
?:pmid
  • 33025954
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Drug Information Association (DIA) Europe - 32nd Annual Meeting, Virtual (June 29-July 3, 2020).
?:type
?:year
  • 2020-09-01

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/dw4vyiba>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/dw4vyiba>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all